Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019
Author:
Funder
Ain Pharmaciez
Tansa
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Link
https://link.springer.com/content/pdf/10.1007/s00192-023-05463-y.pdf
Reference30 articles.
1. Murayama A, Kamamoto S, Saito H, Yamada K, Bhandari D, Shoji I, Mamada H, Kawashima M, Yamashita E, Kusumi E, Sawano T, Sapkota B, Tanimoto T, Ozaki A. Pharmaceutical payments to Japanese board-certified infectious disease specialists: a four-year retrospective analysis of payments from 92 pharmaceutical companies between 2016 and 2019. Int J Environ Res Public Health. 2022;19(12):7417. https://doi.org/10.3390/ijerph19127417.
2. Kusumi E, Murayama A, Kamamoto S, Kawashima M, Yoshida M, Saito H, Sawano T, Yamashita E, Tanimoto T, Ozaki A. Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019. Blood Cancer J. 2022;12(4):54. https://doi.org/10.1038/s41408-022-00656-y.
3. Yamamoto K, Murayama A, Ozaki A, Saito H, Sawano T, Tanimoto T. Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan. Int Urogynecol J. 2021;32(2):443–51. https://doi.org/10.1007/s00192-020-04547-3.
4. Murayama A, Yamada K, Yoshida M, Kaneda Y, Saito H, Sawano T, Shrestha S, Shrestha R, Tanimoto T, Ozaki A. Evaluation of conflicts of interest among participants of the Japanese nephrology clinical practice guideline. Clin J Am Soc Nephrol. 2022;17(6):819–26. https://doi.org/10.2215/CJN.14661121.
5. Tarras ES, Marshall DC, Rosenzweig K, Korenstein D, Chimonas S. Trends in industry payments to medical oncologists in the United States since the inception of the open payments program, 2014 to 2019. JAMA Oncol. 2021;7(3):440–4. https://doi.org/10.1001/jamaoncol.2020.6591.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cross‐sectional analysis of pharmaceutical industry payments to board‐certified breast cancer specialists in Japan;Clinical and Translational Discovery;2024-08
2. Non-research payments to board-certified cardiologists from pharmaceutical industry in Japan from 2016 to 2019: a retrospective analysis;BMJ Open;2024-07
3. Public preferences and willingness to pay for a net zero NHS: a protocol for a discrete choice experiment in England and Scotland;BMJ Open;2024-06
4. Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan;BMJ Open;2024-06
5. Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan;BMC Medical Ethics;2024-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3